Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Clinical Orthodontics : JCO
|
June 25, 2017
Practice Profile: Jeremy Fry, DDS, MS, Fry Orthodontic Specialists
Jeremy Fry, Robert Keim
Transplantation
|
January 26, 2002
Which donor cells facilitate the induction of specific immunological unresponsiveness to alloantigens in vivo?
Kathryn J Wood, J Stephen Billing, Isabelle Binet, et al.
Plos One
|
December 21, 2021
Fc-engineered antibodies with immune effector functions completely abolished
Ian Wilkinson, Stephen Anderson, Jeremy Fry, et al.
Journal of Clinical Orthodontics : JCO
|
February 15, 2020
Digital Office Management
Robert G Keim, W Ronald Redmond, Amy Demas, et al.
Human Gene Therapy
|
April 30, 2003
Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo
Wilson Wong, J Stephen Billing, Sharon A Stranford, et al.
Health Technology Assessment (Winchester, England)
|
April 28, 2016
UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
Damian Griffin, Peter Wall, Alba Realpe, et al.
Eye & Contact Lens
|
July 21, 2017
Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases
Joseph Kovalchin, Bracken King, Allyson Masci, et al.
Clinical and Translational Allergy
|
April 18, 2014
Allergic sensitization: screening methods
Gregory S Ladics, Jeremy Fry, Richard Goodman, et al.
Health Technology Assessment (Winchester, England)
|
March 1, 2022
Arthroscopic hip surgery compared with personalised hip therapy in people over 16 years old with femoroacetabular impingement syndrome: UK FASHIoN RCT
Damian R Griffin, Edward J Dickenson, Felix Achana, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 3, 2017
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky, Jacek Hajda, Assia L Angelova, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Clinical Orthodontics : JCO
|
June 25, 2017
Practice Profile: Jeremy Fry, DDS, MS, Fry Orthodontic Specialists
Jeremy Fry, Robert Keim
Transplantation
|
January 26, 2002
Which donor cells facilitate the induction of specific immunological unresponsiveness to alloantigens in vivo?
Kathryn J Wood, J Stephen Billing, Isabelle Binet, et al.
Plos One
|
December 21, 2021
Fc-engineered antibodies with immune effector functions completely abolished
Ian Wilkinson, Stephen Anderson, Jeremy Fry, et al.
Journal of Clinical Orthodontics : JCO
|
February 15, 2020
Digital Office Management
Robert G Keim, W Ronald Redmond, Amy Demas, et al.
Human Gene Therapy
|
April 30, 2003
Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo
Wilson Wong, J Stephen Billing, Sharon A Stranford, et al.
Health Technology Assessment (Winchester, England)
|
April 28, 2016
UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
Damian Griffin, Peter Wall, Alba Realpe, et al.
Eye & Contact Lens
|
July 21, 2017
Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases
Joseph Kovalchin, Bracken King, Allyson Masci, et al.
Clinical and Translational Allergy
|
April 18, 2014
Allergic sensitization: screening methods
Gregory S Ladics, Jeremy Fry, Richard Goodman, et al.
Health Technology Assessment (Winchester, England)
|
March 1, 2022
Arthroscopic hip surgery compared with personalised hip therapy in people over 16 years old with femoroacetabular impingement syndrome: UK FASHIoN RCT
Damian R Griffin, Edward J Dickenson, Felix Achana, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 3, 2017
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky, Jacek Hajda, Assia L Angelova, et al.
Page
of 2